Search research articles
Contact Us
Filters
Showing results (181-190 of 199) with videos related to
Page
of 20
Sort By:
International Journal of Medical Sciences
|
April 16, 2021
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial
Eriseld Krasniqi, Laura Pizzuti, Maria Rosaria Valerio, et al.
The Lancet. Oncology
|
February 2, 2025
The interplay between acute and late toxicity among patients receiving prostate radiotherapy: an individual patient data meta-analysis of six randomised trials
John Nikitas, Parsa Jamshidian, Alison C Tree, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 6, 2019
International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma
Anne W Lee, Wai Tong Ng, Jian Ji Pan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 4, 2011
Head and neck cancers
David G Pfister, Kie-Kian Ang, David M Brizel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 7, 2012
Mucosal melanoma of the head and neck
David G Pfister, Kie-Kian Ang, David M Brizel, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 11, 2021
International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma
Wai Tong Ng, Yoke Lim Soong, Yong Chan Ahn, et al.
The Lancet. Oncology
|
April 16, 2021
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis
Claire Petit, Benjamin Lacas, Jean-Pierre Pignon, et al.
The Lancet. Oncology
|
March 20, 2025
Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium
Amar U Kishan, Yilun Sun, Alison C Tree, et al.
NPJ Breast Cancer
|
May 29, 2026
Platinum-based neoadjuvant chemotherapy and the predictive role of DNA damage response biomarkers in TNBC: the NeoCarbo study
Eriseld Krasniqi, Anna Di Benedetto, Lorena Filomeno, et al.
Oncotarget
|
September 17, 2017
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience
Patrizia Vici, Laura Pizzuti, Andrea Michelotti, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 199) with videos related to
Sort By:
Page
of 20
International Journal of Medical Sciences
|
April 16, 2021
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial
Eriseld Krasniqi, Laura Pizzuti, Maria Rosaria Valerio, et al.
The Lancet. Oncology
|
February 2, 2025
The interplay between acute and late toxicity among patients receiving prostate radiotherapy: an individual patient data meta-analysis of six randomised trials
John Nikitas, Parsa Jamshidian, Alison C Tree, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 6, 2019
International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma
Anne W Lee, Wai Tong Ng, Jian Ji Pan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 4, 2011
Head and neck cancers
David G Pfister, Kie-Kian Ang, David M Brizel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 7, 2012
Mucosal melanoma of the head and neck
David G Pfister, Kie-Kian Ang, David M Brizel, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 11, 2021
International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma
Wai Tong Ng, Yoke Lim Soong, Yong Chan Ahn, et al.
The Lancet. Oncology
|
April 16, 2021
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis
Claire Petit, Benjamin Lacas, Jean-Pierre Pignon, et al.
The Lancet. Oncology
|
March 20, 2025
Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium
Amar U Kishan, Yilun Sun, Alison C Tree, et al.
NPJ Breast Cancer
|
May 29, 2026
Platinum-based neoadjuvant chemotherapy and the predictive role of DNA damage response biomarkers in TNBC: the NeoCarbo study
Eriseld Krasniqi, Anna Di Benedetto, Lorena Filomeno, et al.
Oncotarget
|
September 17, 2017
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience
Patrizia Vici, Laura Pizzuti, Andrea Michelotti, et al.
Page
of 20